Metformin is the most prescribed glucose-lowering medicine in the world and the first choice in type 2 diabetes; it is also used in prediabetes and insulin resistance. Most likely you left the consulting room with a prescription and a familiar unease: a patient leaflet the size of a bedsheet, and acquaintances who have already informed you that “those tablets drop your sugar until you faint” and “wreck your liver.”
Metformin is one of the most thoroughly studied medicines of the past half-century, and its safety rests not on faith but on a handful of simple lab tests. One of the main fears here is groundless: as monotherapy, metformin almost never causes hypoglycemia. And the point of monitoring is not to hunt for diseases that are not there but to answer two questions: is the treatment working (HbA1c and glucose) and is everything in order on the safety side (the kidneys and vitamin B12). Plus understanding, once, when the drug is temporarily stopped because of the risk of lactic acidosis.
This continues our series on lab monitoring while on medication — the same way we covered what to monitor while taking statins. What follows is about lab monitoring and its rhythm, not about what diabetes is. Doses and regimens are a matter for your treating doctor; here we cover only the laboratory side.
Why lab monitoring matters on metformin — and why it does not cause hypoglycemia
First, the fear that keeps many people from starting treatment. Metformin belongs to the antihyperglycemic rather than the hypoglycemic agents: it lowers the liver’s production of glucose and improves the sensitivity of tissues to insulin, but it does not make the pancreas release insulin. That is why, as the StatPearls review of metformin notes, on monotherapy it is “unlikely to cause hypoglycemia”: it pulls a high sugar down toward normal but does not drag it below. A real risk of low sugar appears in combination with insulin or with sulfonylureas, and also with prolonged fasting and alcohol.
Wizey’s chief medical officer, Dr. Aigerim Bissenova, notes that the fear of “my sugar will drop until I faint” on monotherapy is one of the most common at an appointment and almost always excessive; what matters far more is not skipping the scheduled checks of the kidneys and B12. Metformin is established as first-line therapy for type 2 diabetes in international guidance — the ADA Standards of Care in Diabetes — and its safety there is tied directly to kidney function: the KDIGO 2022 guideline for diabetes management in chronic kidney disease sets out the eGFR limits within which the drug is used. If you are only just finding your way around lab forms, start with the lab test reference: we do not retell it here, we show how the markers add up into a schedule.
HbA1c and glucose: is the treatment working
The main marker of effectiveness is glycated hemoglobin (HbA1c). It reflects the average sugar level over the last 2–3 months and does not require blood to be given strictly fasting. Reference ranges and pitfalls are on its page in the reference; what matters here is the rhythm. While sugar has not reached its target or the dose is changing, HbA1c is checked every 3 months — long enough for the effect of a new dose to show. Once the target is reached and the value is stable, the interval is stretched to roughly 6 months. Between those checkpoints, fasting glucose or home self-monitoring helps you keep your bearings.
What counts as a target is individual, and your doctor sets it. What is realistically achievable in 3–6 months at the level of HbA1c and weight we covered in the piece on whether prediabetes is reversible and which goals are realistic — a good starting point for where to aim. If metformin was prescribed because of insulin resistance (the HOMA-IR index), the logic is the same: what is watched is the trend, not one number on its own.
The kidneys: creatinine and eGFR before starting and over time
This is the key safety check. Metformin is cleared by the kidneys unchanged; if filtration falls, the drug accumulates, and with it the risk of lactic acidosis. That is why creatinine with a calculated eGFR (estimated glomerular filtration rate) is checked before treatment starts and then over time. The reference points, which the 2026 Standards of Care of the American Diabetes Association (ADA) among others rely on:
| eGFR, mL/min/1.73 m² | What it means for metformin | How often to check the kidneys |
|---|---|---|
| ≥ 60 | Used with no restrictions on the dose | Usually once a year |
| 45–60 | Can be continued, but with attention | Every 3–6 months |
| 30–45 | Not started afresh; continued with caution, often at a reduced dose | Roughly every 3 months |
| < 30 | Contraindicated — the drug is stopped | Management is decided by the doctor |
The main point: metformin does not destroy the kidneys — on the contrary, it is their work that determines whether it can be taken. A single raised creatinine is not yet a diagnosis — what is looked at is eGFR over time. Alongside creatinine, urea is assessed: it helps tell dehydration apart from a kidney problem proper.
Vitamin B12: why metformin “eats” it
This is the most underrated link of all. Metformin impairs the absorption of vitamin B12 in the small intestine in a dose-dependent and time-dependent way: the higher the dose and the longer the treatment, the more noticeable the drop. According to the NIH fact sheet on vitamin B12, this is a classic drug-induced mechanism of deficiency, and a review of long-term metformin therapy shows that the risk becomes meaningful on average after several years, while high doses (from around 1,500 mg a day) amplify the effect.
The insidious part is that the symptoms of deficiency — fatigue, numbness and tingling in the feet, an unsteady gait, anemia — are easy to write off as age or as the course of diabetes itself. And B12 deficiency can mimic or worsen diabetic polyneuropathy, which is why it is important not to miss it. Reference ranges and the “gray zone” are on the vitamin B12 page, and why the deficiency so often slips past doctors is in the piece on hidden B12 deficiency.
On the rhythm: the same ADA standards advise checking B12 periodically during long-term use, especially at a high dose, with 4–5 years of treatment behind you, and with risk factors present (strict vegetarianism, stomach surgery, heartburn medicines). The reference point is once every 1–2 years, and after 4 years or when symptoms appear — annually. Alongside B12, folate is looked at: the two vitamins work as a pair in blood formation, and correcting one without the other is wrong.
Lactic acidosis: rare but serious — when to stop the drug and tell your doctor
Lactic acidosis is the complication that gives metformin its stern reputation. The main thing first: it is very rare. According to StatPearls, the incidence is on the order of 1 case per 30,000 patients, and it almost never arises out of nowhere — it comes with accumulation of the drug or a sharp rise in lactate.
The risk factors are predictable: a marked fall in kidney function (that same eGFR below 30), severe dehydration, serious infections, a shortage of oxygen, alcohol abuse, and severe liver failure. Hence the rule: metformin is usually stopped temporarily before procedures that can hit the kidneys — above all before CT with iodinated contrast and planned surgery. For that time the drug is paused and then restarted once the kidneys have been confirmed to be fine. This is not a reason to worry but a routine precaution — it is enough to tell your doctor and the radiologist in advance that you take it.
Red flags: when to see a doctor as soon as possible
- Sudden marked weakness, muscle pain, heavy or rapid breathing, abdominal pain, nausea while on the drug — possible signs of lactic acidosis. An urgent medical assessment is needed; with pronounced symptoms, call emergency services.
- An upcoming CT with contrast or planned surgery — discuss a temporary pause with your doctor in advance, do not decide the question yourself.
- Growing numbness or tingling in the feet, persistent fatigue, pallor — a reason to check vitamin B12 without waiting for the scheduled date.
Liver tests and gut tolerance: what is actually needed
Metformin is not hepatotoxic, so there is no need for everyone to have liver tests every three months as a matter of routine. It makes sense to assess baseline ALT and AST before starting and after that on indication rather than by the calendar. In severe liver failure metformin is not prescribed, but not because of harm to the liver — rather because impaired lactate metabolism in itself raises the risk of lactic acidosis.
What bothers people more often is not the liver but the stomach: nausea, looser stools, and discomfort in the first weeks are a common and usually transient side effect. Tolerance is generally better if the drug is taken with or after food, and the extended-release form is often gentler than the standard one. Choosing the form and the dose is the doctor’s job.
How to build the monitoring rhythm: a simple calendar
A short plan for the conversation with your doctor — this is a reference point, not a self-prescription: the exact frequency is set for your situation.
| What | When and how often | Why |
|---|---|---|
| Glycated hemoglobin (HbA1c) | Every 3 months until the target is reached, then once every 6 months | Effectiveness of treatment |
| Glucose / self-monitoring | On the doctor’s plan, between the HbA1c checkpoints | Current sugar level |
| Creatinine + eGFR | Before starting, then once a year (more often with a reduced eGFR) | Whether to continue and at what dose |
| Vitamin B12 | Once every 1–2 years; after 4 years or when symptoms appear — annually | Preventing a hidden deficiency |
| ALT / AST | Before starting and after that on indication | Assessing the liver, not routinely |
| Lactate | Only when lactic acidosis is suspected | Diagnosing the complication |
As Dr. Aigerim Bissenova notes, the “golden minimum” for most patients looks like this: HbA1c on schedule plus the kidneys and vitamin B12 once a year as planned — that is enough for treatment to stay both effective and safe.
Frequently asked questions
Can metformin cause hypoglycemia (low blood sugar)? As monotherapy — essentially no: metformin does not stimulate insulin release, it lowers the liver’s production of glucose and improves sensitivity to insulin, so on its own it almost never pushes sugar below normal. The risk appears in combination with insulin or sulfonylureas, and also with fasting and alcohol.
Do I need to test vitamin B12 on metformin, and how often? Yes, with long-term use it is sensible: metformin reduces B12 absorption in a dose- and time-dependent way, and the risk of deficiency rises noticeably after 4–5 years and at high doses. The reference point is once every 1–2 years, and after 4 years of treatment or when symptoms appear (numbness, fatigue, anemia) — annually and without waiting for the scheduled date. Agree the frequency with your doctor.
Does metformin ruin the kidneys? No, metformin does not damage the kidneys — on the contrary, it is the kidneys that clear the drug, which is why their function matters. Below an eGFR of 30 mL/min/1.73 m² it is contraindicated, and in the 30–45 range it is used with caution. That is why creatinine with a calculated eGFR is checked before starting and then over time.
Does metformin need to be stopped before a CT scan with contrast or before surgery? Often yes, but that is the doctor’s decision. Iodinated contrast and surgery can temporarily worsen kidney function, and against that background metformin can accumulate, so it is usually paused for the duration of the procedure and restarted once kidney function has been checked. Tell both the radiologist and your treating doctor in advance that you take it.
How often should HbA1c be tested on metformin? While sugar has not reached its target or the dose is changing — usually every 3 months; once the target is reached and the value is stable — roughly once every 6 months. This is a reference point; the exact schedule is set by your treating doctor.
Conclusion
Metformin is a medicine with half a century of history behind it and a predictable safety profile, and monitoring on it comes down to a few clear points: HbA1c for effectiveness, the kidneys and vitamin B12 for safety, and lactic acidosis as a rare situation you simply need to be prepared for.
If you want to gather scattered lab forms into a single picture and see how the markers connect to one another, that is what we build Wizey for: it helps you make sense of your results and put together the questions for your doctor. It is not a substitute for a consultation and not a tool that starts or stops treatment, but a way to arrive at the appointment prepared.
